Ashish Sharma

47PUBLICATIONS

22CO-AUTHORS

BiomechanicsRegenerative medicine (incl. stem cells)Gene and molecular therapyDiagnostic radiographyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (47)

Sort by Publication Date:

|May 16, 2026

Real-world effectiveness and safety of ranibizumab biosimilar FYB-201 in Saudi Arabia (Ravegza) and Jordan (Uptera): a middle eastern extension of the FORCE study.

|Apr 22, 2026

Rethinking phase III trials in retinal biosimilars: Do we still need them?

|Mar 02, 2026

Aflibercept 2 mg Biosimilar (aflibercept-ayyh, Pavblu): Experience of safety in clinical settings-APEX- safety study.

Ashish Sharma, Arshad M Khanani, David Eichenbaum

|Dec 10, 2025

Aflibercept vs ranibizumab biosimilars: manufacturing differences that might matter in the long run.

Ashish Sharma, Francesco Bandello, Sanjay Bandyopadhyay

|Oct 02, 2025

Ashish Sharma, Luke Nicholson, Clara Vazquez-Alfageme

|May 03, 2025

Aflibercept 2 mg biosimilar (Tyalia)-real-world experience from IRAN (ATRIA study).

Sahar Avadzadeh, Ashish Sharma, Mohammad Mehdi Parvaresh

Pageof 8

Frequent Collaborators

33 joint publications

Nilesh Kumar

24 joint publications

Francesco Bandello

Anat Loewenstein

Taku Wakabayashi

Peter Kaiser

Se Joon Woo

Giulia Corradetti

Adam T Chin

Usha Chakravarthy

Arshad M Khanani

Frequent Collaborators

33 joint publications

Nilesh Kumar

24 joint publications

Francesco Bandello

9 joint publications

Anat Loewenstein

4 joint publications

Taku Wakabayashi